Recent EXAS News
- Form 8-K - Current report • Edgar (US Regulatory) • 06/03/2024 11:01:05 AM
- Exact Sciences to Participate in June Investor Conferences • Business Wire • 05/28/2024 10:00:00 AM
- Exact Sciences bekräftigt mit mehreren Datenpräsentationen seine langfristige Vorreiterrolle in der Krebsfrüherkennung und bei der Verbesserung von Behandlungsergebnissen • Business Wire • 05/25/2024 11:32:00 AM
- Exact Sciences démontre son leadership continu en matière de diagnostic précoce du cancer et d’amélioration des résultats pour les patients grâce à de multiples présentations de données à l’ASCO® • Business Wire • 05/24/2024 04:46:00 PM
- Exact Sciences Demonstrates Continued Leadership in Early Cancer Diagnosis and Improved Health Outcomes for Patients with Multiple Data Presentations at ASCO® • Business Wire • 05/24/2024 10:05:00 AM
- Exact Sciences Earns 2024 Great Place To Work® Certification™ • Business Wire • 05/22/2024 11:30:00 AM
- Court Ruling Enables Exact Sciences to Proceed with Lawsuit against Geneoscopy • Business Wire • 05/21/2024 10:05:00 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 05/20/2024 08:30:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/08/2024 09:10:47 PM
- Form 424B7 - Prospectus [Rule 424(b)(7)] • Edgar (US Regulatory) • 05/08/2024 09:08:47 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/08/2024 09:03:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/08/2024 08:08:13 PM
- Exact Sciences Announces First-Quarter 2024 Results • Business Wire • 05/08/2024 08:05:00 PM
- U.S. Futures Slightly Dip Amid Corporate Earnings and Quiet Economic Calendar, Oil Prices Fall • IH Market News • 05/08/2024 12:29:17 PM
- Exact Sciences Demonstrates Continued Scientific Advancement in Colorectal Cancer Screening with Multiple Data Presentations at DDW® 2024 • Business Wire • 05/07/2024 12:00:00 PM
- Exact Sciences to Participate in May Investor Conference • Business Wire • 05/01/2024 10:00:00 AM
- Exact Sciences Names Aaron Bloomer as New Chief Financial Officer • Business Wire • 04/15/2024 10:00:00 AM
- Exact Sciences Announces Debt Exchange Transaction and Private Placement of Convertible Senior Notes • Business Wire • 04/11/2024 10:00:00 AM
- Exact Sciences to Present Late-Breaking Data from ASCEND-2 Study Validating Its Investigational Multi-Cancer Early Detection Test at AACR Annual Meeting 2024 • Business Wire • 04/08/2024 04:05:00 PM
- Exact Sciences Schedules First Quarter 2024 Earnings Call • Business Wire • 04/08/2024 10:00:00 AM
- Exact Sciences to Provide Mayo Clinic Patients with Individualized Cancer Tumor Information to Inform Treatment • Business Wire • 04/04/2024 10:05:00 AM
- Exact Sciences Advances Development of Non-Endoscopic Oncoguard® Esophagus Test to Screen for Esophageal Cancer and Pre-Cancer • Business Wire • 03/28/2024 10:00:00 AM
- Exact Sciences Named 2024 Gallup Exceptional Workplace Award Winner • Business Wire • 03/27/2024 12:05:00 PM
- The New England Journal of Medicine Publishes Cologuard Plus™ Test Results from Pivotal BLUE-C Study • Business Wire • 03/13/2024 09:03:00 PM
- Exact Sciences and Basketball Great Jamal Mashburn Encourage Americans 45+ to Have a Game Plan Against Colon Cancer • Business Wire • 03/07/2024 12:59:00 PM
FEATURED DaBaby and Stunna 4 Vegas's "NO DRIBBLE" Joins Music Licensing, Inc.'s Portfolio • Jun 7, 2024 10:15 AM
Mushrooms Inc. (OTC: MSRM) Announces Significant Share Buy Back by the Board Director and New Strategic Initiatives. • MSRM • Jun 5, 2024 1:32 PM
Hydromer Announces Launch of HydroThrombX Medical Device Coating Technology • HYDI • Jun 5, 2024 10:24 AM
Dr. Michael Dent Finances $1 Million to Drive HealthLynked's Healthcare Transformation • HLYK • Jun 5, 2024 8:00 AM
Avant Technologies Enters Binding LOI to Purchase Dozens of High-Performance, Immersible, AI-Powered Servers • AVAI • Jun 5, 2024 8:00 AM
IQST - iQSTEL Announces $290 Million 2024 Annual Revenue Forecast • IQST • Jun 4, 2024 1:43 PM